Loading…
Loading…
EQUITY / NASDAQ · XNCM
Quantum BioPharma Ltd. Class B Subordinate Voting Shares
No accepted understanding yet. Follow this company to establish research where evidence supports it.
Open research workspace →01/01/2025 – 12/31/2025 · USD · Units
Reported figures establish facts for this period; they do not by themselves establish a profitability trend.
Open report ↗3.44 USD
Observed: 10/02/2026 · tickerlayer · Historical end-of-day close
Powered by TickerLayer
10/02/2026 · 3.44 USD · Volume 79,327
250 actual observations · Latest bar: 2026-10-02 · Market data is indicative; provider terms apply.
3 available financial reports
Research reports →SEC FINANCIAL REPORTS
01/01/2025 – 12/31/2025 · Units
| Metric | 2025 / Year end | 2024 / Year end | Change |
|---|---|---|---|
| Operating profit | -15,302,374 USD | — | — |
| Operating cash flow | -8,237,012 USD | -6,876,479 USD | — |
| Cash and cash equivalents | 1,905,357 USD | 5,995,872 USD | -68.22% |
| Total liabilities | 6,058,294 USD | 6,678,992 USD | -9.29% |
| Total equity | 5,102,615 USD | 10,440,232 USD | -51.13% |
Changes are calculated only for matching period length, consolidation, currency, and scale. Percentages are not shown for zero or negative baselines.
Each column uses its report's scale. Check column headers before comparing different consolidation scopes and scales.
| Financial metric | 2025 / Year end01/01/2025 – 12/31/2025ConsolidatedUnits · USD | 2024 / Year end01/01/2024 – 12/31/2024ConsolidatedUnits · USD | 2023 / Year end01/01/2023 – 12/31/2023ConsolidatedUnits · USD |
|---|---|---|---|
| Cash and cash equivalentsBalance sheet | 1,905,357 USD | 5,995,872 USD | 2,757,040 USD |
| Financing cash flowCash flow statement | 6,098,966 USD | 11,618,870 USD | -3,126,589 USD |
| Investing cash flowCash flow statement | -1,952,469 USD | -1,503,559 USD | -269,579 USD |
| Operating cash flowCash flow statement | -8,237,012 USD | -6,876,479 USD | -10,827,264 USD |
| Operating profitIncome statement | -15,302,374 USD | — | -23,789,498 USD |
| Total assetsBalance sheet | 11,160,909 USD | 17,119,224 USD | — |
| Total equityBalance sheet | 5,102,615 USD | 10,440,232 USD | 12,909,262 USD |
| Total liabilitiesBalance sheet | 6,058,294 USD | 6,678,992 USD | — |
| Report source | Open report ↗ Published: 03/26/2026 | Open report ↗ Published: 03/31/2025 | Open report ↗ Published: 03/26/2026 |
The latest available source version is shown for each period. Previous versions and correction relationships are not shown in this view.